/Investor DB

Waterloo Accelerator Centre — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

illumiSonicsillumisonics.cominMay 2022

illumiSonics develops MLI™, a proprietary molecular imaging platform that extracts diagnostic information from unstained tissue samples for use in pathology, surgical imaging, and ophthalmology.

AI & Machine LearningDeep TechHealthtechMedical DevicesWaterloo, CA

Dr. John Mackey(Chief Executive Officer)Parsin Haji Reza(Executive Officer, Director)Jochen Schweizer(Executive Officer)Bruce Johnson(Director)Rocky Ganske(Executive Officer)John Mackey(Executive Officer, Director)

Co-investorsCouncil

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.